Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms

Journal of Neurosurgery

Volumn 119, Issue 2, 2013, Pages 427-433

  Nduom, Edjah K ^a,b   Yang, Chunzhang ^a   Merrill, Marsha J ^a   Zhuang, Zhengping ^a   Lonser, Russell R ^a,c  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Blood brain barrier; Brain metastasis; Brain tumor; Contrast enhancement; Glioma; Oncology

Indexed keywords

AQUAPORIN 4; CD31 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN;

ADULT; AGED; ARTICLE; ASTROCYTE; ASTROCYTOMA; BLOOD BRAIN BARRIER; BRAIN TUMOR; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; AGED; ASTROCYTES; ASTROCYTOMA; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 84881186425     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2013.3.JNS122226     Document Type: Article

References (37)

1. Abbott NJ, Rönnbäck L, Hansson E: Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7: 41-53, 2006 (Pubitemid 41828930)
2. Albelda SM, Muller WA, Buck CA, Newman PJ: Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell-cell adhesion molecule. J Cell Biol 114: 1059-1068, 1991 (Pubitemid 21909867)
3. Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW: Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem 274:23463-23467, 1999
4. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW: Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Diabetes 47:1953-1959, 1998 (Pubitemid 28549205)
5. Caraglia M, De Rosa G, Salzano G, Santini D, Lamberti M, Sperlongano P, et al: Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier. Curr Cancer Drug Targets 12:186-196, 2012
6. Cardoso FL, Brites D, Brito MA: Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches. Brain Res Brain Res Rev 64:328-363, 2010
7. Claes A, Idema AJ, Wesseling P: Diffuse glioma growth: A guerilla war. Acta Neuropathol 114:443-458, 2007 (Pubitemid 47521501)
8. Ellemann K, Christensen L, Gjerris F, Briand P, Kruse-Larsen C: Glucocorticoid receptors in glioblastoma multiforme: A new approach to antineoplastic glucocorticoid therapy. Acta Neurochir (Wien) 93:6-9, 1988
9. Ezan P, André P, Cisternino S, Saubaméa B, Boulay AC, Doutremer S, et al: Deletion of astroglial connexins weakens the blood-brain barrier. J Cereb Blood Flow Metab 32:1457-1467, 2012
10. Fazakas C, Wilhelm I, Nagyoszi P, Farkas AE, Haskó J, Molnár J, et al: Transmigration of melanoma cells through the blood-brain barrier: role of endothelial tight junctions and melanoma-released serine proteases. PLoS ONE 6:e20758, 2011
11. Fidler IJ, Yano S, Zhang RD, Fujimaki T, Bucana CD: The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol 3:53-57, 2002 (Pubitemid 34121146)
12. Förster C, Waschke J, Burek M, Leers J, Drenckhahn D: Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific. J Physiol 573:413-425, 2006 (Pubitemid 43871056)
13. Fortin D: The blood-brain barrier: its influence in the treatment of brain tumors metastases. Curr Cancer Drug Targets 12:247-259, 2012
14. Habgood MD, Begley DJ, Abbott NJ: Determinants of passive drug entry into the central nervous system. Cell Mol Neurobiol 20:231-253, 2000 (Pubitemid 30091458)
15. Hawkins BT, Davis TP: The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57:173-185, 2005 (Pubitemid 41043883)
16. Heiss JD, Papavassiliou E, Merrill MJ, Nieman L, Knightly JJ, Walbridge S, et al: Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor. J Clin Invest 98:1400-1408, 1996 (Pubitemid 26322065)
17. Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WE, Goldbrunner R, Herms J, et al: Real-time imaging reveals the single steps of brain metastasis formation. Nat Med 16:116-122, 2010
18. Kotsarini C, Griffiths PD, Wilkinson ID, Hoggard N: A systematic review of the literature on the effects of dexamethasone on the brain from in vivo human-based studies: implications for physiological brain imaging of patients with intracranial tumors. Neurosurgery 67:1799-1815, 2010
19. Liebner S, Fischmann A, Rascher G, Duffner F, Grote EH, Kalbacher H, et al: Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol 100:323-331, 2000 (Pubitemid 30456160)
20. Lohle PN, Wurzer HA, Seelen PJ, Kingma LM, Go KG: Analysis of fluid in cysts accompanying various primary and metastatic brain tumours: proteins, lactate and pH. Acta Neurochir (Wien) 140:14-19, 1998 (Pubitemid 28052620)
21. Lohle PN, Wurzer HA, Seelen PJ, Kingma LM, Go KG: The pathogenesis of cysts accompanying intra-axial primary and metastatic tumors of the central nervous system. J Neurooncol 40:277-285, 1998 (Pubitemid 29054665)
22. Lonser RR, Vortmeyer AO, Butman JA, Glasker S, Finn MA, Ammerman JM, et al: Edema is a precursor to central nervous system peritumoral cyst formation. Ann Neurol 58:392-399, 2005 (Pubitemid 41266625)
23. Mehta AI, Brufsky AM, Sampson JH: Therapeutic approaches for HER2-positive brain metastases: circumventing the bloodbrain barrier. Cancer Treat Rev 39:261-269, 2013
24. Mitic LL, Anderson JM: Molecular architecture of tight junctions. Annu Rev Physiol 60:121-142, 1998 (Pubitemid 28157867)
25. Muldoon LL, Alvarez JI, Begley DJ, Boado RJ, Del Zoppo GJ, Doolittle ND, et al: Immunologic privilege in the central nervous system and the blood-brain barrier. J Cereb Blood Flow Metab 33:13-21, 2013
26. Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD: Bloodbrain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 1:223-236, 2006 (Pubitemid 44244128)
27. Petty MA, Lo EH: Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog Neurobiol 68:311-323, 2002 (Pubitemid 36071509)
28. Raff MC, Fields KL, Hakomori SI, Mirsky R, Pruss RM, Winter J: Cell-type-specific markers for distinguishing and studying neurons and the major classes of glial cells in culture. Brain Res 174:283-308, 1979 (Pubitemid 9229564)
29. Romero IA, Radewicz K, Jubin E, Michel CC, Greenwood J, Couraud PO, et al: Changes in cytoskeletal and tight junctional proteins correlate with decreased permeability induced by dexamethasone in cultured rat brain endothelial cells. Neurosci Lett 344:112-116, 2003 (Pubitemid 36628019)
30. Rössler K, Neuchrist C, Kitz K, Scheiner O, Kraft D, Lassmann H: Expression of leucocyte adhesion molecules at the human blood-brain barrier (BBB). J Neurosci Res 31:365-374, 1992
31. Seelbach M, Chen L, Powell A, Choi YJ, Zhang B, Hennig B, et al: Polychlorinated biphenyls disrupt blood-brain barrier integrity and promote brain metastasis formation. Environ Health Perspect 118:479-484, 2010
32. Spiegl-Kreinecker S, Buchroithner J, Elbling L, Steiner E, Wurm G, Bodenteich A, et al: Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes. J Neurooncol 57:27-36, 2002 (Pubitemid 34692611)
33. Underwood JL, Murphy CG, Chen J, Franse-Carman L, Wood I, Epstein DL, et al: Glucocorticoids regulate transendothelial fluid flow resistance and formation of intercellular junctions. Am J Physiol 277:C330-C342, 1999 (Pubitemid 29415048)
34. Warth A, Kröger S, Wolburg H: Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae. Acta Neuropathol 107:311-318, 2004 (Pubitemid 38477357)
35. Willis CL, Leach L, Clarke GJ, Nolan CC, Ray DE: Reversible disruption of tight junction complexes in the rat bloodbrain barrier, following transitory focal astrocyte loss. Glia 48:1-13, 2004 (Pubitemid 39390843)
36. Willis CL, Nolan CC, Reith SN, Lister T, Prior MJ, Guerin CJ, et al: Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood-brain barrier in the apparent absence of direct astrocytic contact. Glia 45:325-337, 2004 (Pubitemid 38332433)
37. Wolburg H, Wolburg-Buchholz K, Kraus J, Rascher-Eggstein G, Liebner S, Hamm S, et al: Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol 105:586-592, 2003 (Pubitemid 36798859)